Liver fibrosis biomarkers as a prognostic tool beyond the defining components in cardiovascular-kidney-metabolic syndrome.

Am J Prev Cardiol · 2026 · PMC13084111 · PMID 42006415

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

partially significantno p-value reported

Table S9 indicates that CKM-Liver offered only marginal discriminatory gains over the original CKM staging, with partially significant reclassification improvements.

also in 417 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.